Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Hepatitis C viral infection and the risk of dementia.

Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC; Health Data Analysis in Taiwan (hDATa) Research Group.

Eur J Neurol. 2014 Aug;21(8):1068-e59. doi: 10.1111/ene.12317. Epub 2013 Dec 7.

PMID:
24313931
2.

Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.

Yang YH, Chen WC, Tsan YT, Chen MJ, Shih WT, Tsai YH, Chen PC.

J Hepatol. 2015 Nov;63(5):1111-7. doi: 10.1016/j.jhep.2015.07.006. Epub 2015 Jul 18.

PMID:
26196278
3.
4.

Diverticular disease and additional comorbidities associated with increased risk of dementia.

Peng YC, Lin CL, Yeh HZ, Tung CF, Chang CS, Kao CH.

J Gastroenterol Hepatol. 2016 Nov;31(11):1816-1822. doi: 10.1111/jgh.13389.

PMID:
27029523
5.

Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan.

Lin SY, Chen TC, Lu PL, Lin CY, Lin WR, Yang YH, Chen YH.

BMC Infect Dis. 2014 Dec 19;14:705. doi: 10.1186/s12879-014-0705-y.

6.

Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.

Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH.

Hepatology. 2016 Mar;63(3):721-30. doi: 10.1002/hep.28387. Epub 2016 Jan 14.

PMID:
26662347
7.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB; Canadian Observational Cohort (CANOC) Collaboration.

BMC Infect Dis. 2017 Apr 4;17(1):246. doi: 10.1186/s12879-017-2350-8.

8.
9.

Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.

Tsai HH, Liou HH, Muo CH, Lee CZ, Yen RF, Kao CH.

Neurology. 2016 Mar 1;86(9):840-6. doi: 10.1212/WNL.0000000000002307. Epub 2015 Dec 23.

PMID:
26701382
10.

Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease: A Nationwide Population-Based Study.

Wu PH, Lin YT, Hsieh KP, Chuang HY, Sheu CC.

Medicine (Baltimore). 2015 Aug;94(33):e1328. doi: 10.1097/MD.0000000000001328.

11.

Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, Giordano TP, Landgren O.

Arch Intern Med. 2009 Feb 23;169(4):357-63. doi: 10.1001/archinternmed.2008.576.

12.

Does hepatitis C virus infection increase risk for stroke? A population-based cohort study.

Liao CC, Su TC, Sung FC, Chou WH, Chen TL.

PLoS One. 2012;7(2):e31527. doi: 10.1371/journal.pone.0031527. Epub 2012 Feb 20.

13.

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, Wong J, Tyndall MW, Janjua NZ; British Columbia Hepatitis Testers Cohort (BC-HTC) team.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210. doi: 10.1016/S2468-1253(16)30182-0. Epub 2016 Dec 23. Erratum in: Lancet Gastroenterol Hepatol. 2017 Mar;2(3):e2.

PMID:
28404135
14.

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA.

PLoS One. 2017 Mar 6;12(3):e0173125. doi: 10.1371/journal.pone.0173125. eCollection 2017.

15.

Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study.

Hsu YH, Muo CH, Liu CY, Tsai WC, Hsu CC, Sung FC, Kao CH.

J Hepatol. 2015 Mar;62(3):519-25. doi: 10.1016/j.jhep.2014.09.022. Epub 2014 Sep 28.

PMID:
25263004
16.

Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan.

Su FH, Chang SN, Chen PC, Sung FC, Huang SF, Chiou HY, Su CT, Lin CC, Yeh CC.

PLoS One. 2012;7(10):e48109. doi: 10.1371/journal.pone.0048109. Epub 2012 Oct 25.

17.

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.

18.

Angiotension receptor blockers reduce the risk of dementia.

Chiu WC, Ho WC, Lin MH, Lee HH, Yeh YC, Wang JD, Chen PC; Health Data Analysis in Taiwan (hDATa) Research Group.

J Hypertens. 2014 Apr;32(4):938-47. doi: 10.1097/HJH.0000000000000086.

PMID:
24406780
19.

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP.

Hepatology. 2009 Jan;49(1):116-23. doi: 10.1002/hep.22606.

20.

Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Tsan YT, Lee CH, Wang JD, Chen PC.

J Clin Oncol. 2012 Feb 20;30(6):623-30. doi: 10.1200/JCO.2011.36.0917. Epub 2012 Jan 23. Erratum in: J Clin Oncol. 2013 Aug 20;31(24):3049.

PMID:
22271485

Supplemental Content

Support Center